novo nordisk glp 1 products Novo's Wegovy becomes first GLP-1 drug approved for MASH Comparing Ozempic, Wegovy and Other

Description

PBM pricing

Learn strategies to adjust your eating habits and portion sizes while on GLP-1 medication to ensure proper nutrition.

On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established "Green List.

Explore the current evidence on whether semaglutide is linked to postural orthostatic tachycardia syndrome, understand Wegovy's cardiovascular effects, and learn when to seek medical advice whilst taking this weight management medication.

The Risks: Unknown ingredients and contamination Incorrect dosages and life-threatening side effects No regulatory oversight or safety data Why This Is Critical: Patients are bypassing pharmacies and getting injections from sketchy online vendors This undermines real GLP1 therapies and can lead to serious harm As healthcare professionals, we must: Ask patients about the source of their medications Report adverse reactions to MedWatch Educate our patients about safe access and real prescriptions Lets advocate for ethical prescribing and responsible patient care in the GLP1 era